South Africa Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

South Africa Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to South Africa diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in South Africa

Scope

• The report provides diabetes care devices information broken down into detailed categories and segments in South Africa.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the diabetes care devices market in South Africa.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

• 1 Table of Contents
  • 1.1 1.2 2 Introduction
  • 2.1 What Is This Report About?
• 3 Definitions of Markets Covered in the Report
  • 3.1 Diabetic Care Devices
  • 3.2 Glucose Monitoring Devices
    • 3.2.1 Blood Glucose Meters
    • 3.2.2 Blood Glucose Strips
  • 3.3 Insulin Delivery
    • 3.3.1 Insulin Pens
    • 3.3.2 Insulin Syringes
    • 3.3.3 Insulin Pumps
    • 3.3.4 Traditional Insulin Pump Accessories
• 4 Healthcare Sector Review
  • 4.1 Proposed Health System in South Africa
• 5 Regulation System
  • 5.1 Medical Equipment Regulation System
  • 5.2 Regulation of Electromagnetic Medical Devices
  • 5.3 Future Outlook
• 6 Pricing and Reimbursement
  • 6.1 Reimbursement
  • 6.2 Pricing
• 7 Distribution Structure
• 8 Diabetes Care Devices In South Africa
  • 8.1 Diabetes Care Devices, South Africa, Overall Revenue ($ mn), 2000-2015
  • 8.2 Diabetes Care Devices, South Africa, Category Volume (Units), 2000-2015
  • 8.3 Diabetes Care Devices, South Africa, Company Share (2007-2008)
• 9 Glucose Monitoring In South Africa
  • 9.1 Glucose Monitoring Overall Revenue (2000-2015)
  • 9.2 Glucose Monitoring Overall Volume (2000-2015)
  • 9.3 Glucose Monitoring Average Price (2000-2015)
  • 9.4 Glucose Monitoring Distribution Share (2007-2008)
  • 9.5 Glucose Monitoring, South Africa, Company Share (2007-2008)
• 10 Insulin Delivery In South Africa
  • 10.1 Insulin Delivery Overall Revenue (2000-2015)
    • 10.1.1 Insulin Pens Revenue (2000-2015)
  • 10.2 Insulin Delivery Overall Volume (2000-2015)
    • 10.2.1 Insulin Pens Volume (2000-2015)
  • 10.3 Insulin Delivery Average Price (2000-2015)
  • 10.4 Insulin Delivery Distribution Share (2007-2008)
  • 10.5 Insulin Delivery, South Africa, Company Share (2007-2008)
• 11 Overview of Key Companies in South Africa Diabetes Care Devices Market
  • 11.1 Terumo Corporation
    • 11.1.1 Company Overview
    • 11.1.2 Value Chain Analysis
  • 11.2 Smiths Medical
    • 11.2.1 Company Overview
    • 11.2.2 Value Chain Analysis
  • 11.3 Sanofi-Aventis
    • 11.3.1 Company Overview
  • 11.4 Novo Nordisk A/S
    • 11.4.1 Company Overview
    • 11.4.2 Novo Nordisk A/S Pipeline Products
  • 11.5 Medtronic, Inc
    • 11.5.1 Company Overview
    • 11.5.2 Value Chain Analysis
    • 11.5.3 Medtronic, Inc. Pipeline Products
  • 11.6 LifeScan, Inc
    • 11.6.1 Company Overview
    • 11.6.2 LifeScan, Inc. Pipeline Products
  • 11.7 F. Hoffmann-La Roche Ltd
    • 11.7.1 Company Overview
    • 11.7.2 Value Chain Analysis
    • 11.7.3 F. Hoffmann-La Roche Ltd Pipeline Products
  • 11.8 Eli Lilly and Company
    • 11.8.1 Company Overview
    • 11.8.2 Value Chain Analysis
    • 11.8.3 Eli Lilly and Company Pipeline Products
  • 11.9 Becton, Dickinson and Company
    • 11.9.1 Company Overview
    • 11.9.2 Value Chain Analysis
  • 11.10 Bayer HealthCare AG
    • 11.10.1 Company Overview
    • 11.10.2 Value Chain Analysis
    • 11.10.3 Bayer HealthCare AG Pipeline Products
  • 11.11 Apex Biotechnology Corp
    • 11.11.1 Company Overview
  • 11.12 Animas Corporation
    • 11.12.1 Company Overview
  • 11.13 Abbott Laboratories
    • 11.13.1 Company Overview
    • 11.13.2 Value Chain Analysis
    • 11.13.3 Abbott Laboratories Pipeline Products
• 12 Appendix
  • 12.1 Global Markets Direct Research Methodology
  • 12.2 Coverage
  • 12.3 Secondary Research
  • 12.4 Primary Research
  • 12.5 Models
  • 12.6 Forecasts
  • 12.7 Expert Panel Validation
  • 12.8 Currency Conversion
  • 12.9 Contact Us
  • 12.10 Disclaimer
• 1.1 List of Tables
  • Table 1: Healthcare Statistics, South Africa, 2000-2008
  • Table 2: Healthcare Expenditure, South Africa, 2000-2008
  • Table 3: South Africa Trade Statistics, 2004-2008
  • Table 4: Diabetes Care Devices, South Africa, Overall Revenue ($ mn), 2000-2015
  • Table 5: Diabetes Care Devices, South Africa, Cross-Category Analysis, 2000-2015
  • Table 6: Diabetes Care Devices, South Africa, Overall Revenue ($ mn), Historic, 2000-2008
  • Table 7: Diabetes Care Devices, South Africa, Overall Revenue ($ mn), Forecast, 2008-2015
  • Table 8: Diabetes Care Devices, South Africa, Category Volume (Units), 2000-2015
  • Table 9: Diabetes Care Devices, South Africa, Category Volume (Units), Historic, 2000-2008
  • Table 10: Diabetes Care Devices, South Africa, Category Volume (Units), Forecast, 2008-2015
  • Table 11: Diabetes Care Devices, South Africa, Company Share by Revenue ($ mn), 2007-2008
  • Table 12: Glucose Monitoring, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Table 13: Glucose Monitoring, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Table 14: Glucose Monitoring, South Africa, Volume (Units) by Segment, Historic, 2000-2008
  • Table 15: Glucose Monitoring, South Africa, Volume (Units) by Segment, Forecast, 2008-2015
  • Table 16: Glucose Monitoring, South Africa, Average Price ($), Historic, 2000-2008
  • Table 17: Glucose Monitoring, South Africa, Average Price ($), Forecast, 2008-2015
  • Table 18: Glucose Monitoring, South Africa, Distribution Share by Revenue ($mn), 2007-2008
  • Table 19: Glucose Monitoring, South Africa, Company Share by Revenue ($ mn), 2007-2008
  • Table 20: Insulin Delivery, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Table 21: Insulin Delivery, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Table 22: Insulin Pens, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 23: Insulin Pens, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 24: Insulin Delivery, South Africa, Volume (Units) by Segment, Historic, 2000-2008
  • Table 25: Insulin Delivery, South Africa, Volume (Units) by Segment, Forecast, 2008-2015
  • Table 26: Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2008
  • Table 27: Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Forecast, 2008-2015
  • Table 28: Insulin Delivery, South Africa, Average Price ($), Historic, 2000-2008
  • Table 29: Insulin Delivery, South Africa, Average Price ($), Forecast, 2008-2015
  • Table 30: Insulin Delivery, South Africa, Distribution Share by Revenue ($mn), 2007-2008
  • Table 31: Insulin Delivery, South Africa, Company Share by Revenue ($ mn), 2007-2008
  • Table 32: Novo Nordisk A/S Pipeline Products by Equipment Type
  • Table 33: Novo Nordisk A/S Pipeline Products By Development Stage
  • Table 34: Novo Nordisk A/S Pipeline Products By Therapy Area
  • Table 35: Novo Nordisk A/S Pipeline Products By Clinical Trials
  • Table 36: Medtronic, Inc. Pipeline Products by Equipment Type
  • Table 37: Medtronic, Inc. Pipeline Products By Development Stage
  • Table 38: Medtronic, Inc. Pipeline Products By Therapy Area
  • Table 39: Medtronic, Inc. Pipeline Products By Clinical Trials
  • Table 40: Medtronic, Inc. Pipeline Products By News Summary
  • Table 41: LifeScan, Inc. Pipeline Products by Equipment Type
  • Table 42: LifeScan, Inc. Pipeline Products By Development Stage
  • Table 43: LifeScan, Inc. Pipeline Products By Therapy Area
  • Table 44: LifeScan, Inc. Pipeline Products By Clinical Trials
  • Table 45: LifeScan, Inc. Pipeline Products By News Summary
  • Table 46: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
  • Table 47: F. Hoffmann-La Roche Ltd Pipeline Products By Development Stage
  • Table 48: F. Hoffmann-La Roche Ltd Pipeline Products By Therapy Area
  • Table 49: Eli Lilly and Company Pipeline Products by Equipment Type
  • Table 50: Eli Lilly and Company Pipeline Products By Development Stage
  • Table 51: Eli Lilly and Company Pipeline Products By Therapy Area
  • Table 52: Eli Lilly and Company Pipeline Products By Clinical Trials
  • Table 53: Eli Lilly and Company Pipeline Products By News Summary
  • Table 54: Bayer HealthCare AG Pipeline Products by Equipment Type
  • Table 55: Bayer HealthCare AG Pipeline Products By Development Stage
  • Table 56: Bayer HealthCare AG Pipeline Products By Therapy Area
  • Table 57: Bayer HealthCare AG Pipeline Products By News Summary
  • Table 58: Abbott Laboratories Pipeline Products by Equipment Type
  • Table 59: Abbott Laboratories Pipeline Products By Development Stage
  • Table 60: Abbott Laboratories Pipeline Products By Therapy Area
  • Table 61: USD to Local Currency, Average Exchange Rate 2008
• 1.2 List of Figures
  • Figure 1: Diabetes Care Devices, South Africa, Overall Revenue ($ mn), 2000-2015
  • Figure 2: Diabetes Care Devices, South Africa, Cross-Category Analysis, 2000-2015
  • Figure 3: Diabetes Care Devices, South Africa, Overall Revenue ($ mn), Historic, 2000-2008
  • Figure 4: Diabetes Care Devices, South Africa, Overall Revenue ($ mn), Forecast, 2008-2015
  • Figure 5: Diabetes Care Devices, South Africa, Category Volume (Units), 2000-2015
  • Figure 6: Diabetes Care Devices, South Africa, Category Volume (Units), Historic, 2000-2008
  • Figure 7: Diabetes Care Devices, South Africa, Category Volume (Units), Forecast, 2008-2015
  • Figure 8: Diabetes Care Devices, South Africa, Company Share (%), 2008
  • Figure 9: Glucose Monitoring, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Figure 10: Glucose Monitoring, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Figure 11: Glucose Monitoring, South Africa, Volume (Units) by Segment, Historic, 2000-2008
  • Figure 12: Glucose Monitoring, South Africa, Volume (Units) by Segment, Forecast, 2008-2015
  • Figure 13: Glucose Monitoring, South Africa, Company Share (%), 2008
  • Figure 14: Insulin Delivery, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Figure 15: Insulin Delivery, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Figure 16: Insulin Pens, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 17: Insulin Pens, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 18: Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2008
  • Figure 19: Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Forecast, 2008-2015
  • Figure 20: Insulin Delivery, South Africa, Company Share (%), 2008
  • Figure 21: Terumo Corporation Value Chain Analysis
  • Figure 22: Smiths Medical Value Chain Analysis
  • Figure 23: Medtronic, Inc. Value Chain Analysis
  • Figure 24: F. Hoffmann-La Roche Ltd Value Chain Analysis
  • Figure 25: Eli Lilly and Company Value Chain Analysis
  • Figure 26: Becton, Dickinson and Company Value Chain Analysis
  • Figure 27: Bayer HealthCare AG Value Chain Analysis
  • Figure 28: Abbott Laboratories Value Chain Analysis
  • Figure 29: Global Markets Direct Methodology